The lab-on-skin microfluidic patch market size has grown exponentially in recent years. It will grow from $1.44 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to advances in microfluidics, wearable healthcare technology adoption, growth of sports analytics, increasing demand for non-invasive diagnostics, research in biofluid analysis.
The lab-on-skin microfluidic patch market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to integration with AI-driven analytics, expansion in personalized medicine, remote patient monitoring growth, adoption in fitness & wellness sectors, technological innovation in patch materials. Major trends in the forecast period include continuous health monitoring, non-invasive diagnostics, personalized medicine devices, sports & fitness analytics, real-time biomarker detection.
The growing focus on personalized medicine is anticipated to drive the expansion of the lab-on-skin microfluidic patch market in the coming years. Personalized medicine is a healthcare approach that tailors medical treatment and preventive strategies to an individual’s genetic, biomarker, and clinical profile to achieve better therapeutic outcomes. The increasing adoption of personalized medicine is supported by advances in genomics and biotechnology, which enable accurate diagnoses and targeted therapies that enhance treatment effectiveness and reduce unnecessary interventions. Lab-on-skin microfluidic patches contribute to this approach by continuously monitoring unique biomarkers, allowing real-time, individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization promoting personalized medicine, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Therefore, the rising emphasis on personalized medicine is propelling the growth of the lab-on-skin microfluidic patch market.
Companies operating in the lab-on-skin microfluidic patch market are increasingly developing advanced microfluidic technologies, such as sweat-sensing patches, to support real-time health monitoring and personalized diagnostics. A sweat-sensing patch is a wearable device that collects and analyzes sweat to track biomarkers, electrolytes, and other physiological indicators continuously. For example, in April 2024, Epicore Biosystems Inc., a US-based digital health company, launched Connected Hydration, a wearable microfluidic patch paired with a mobile application that helps industrial workers prevent dehydration and heat stress through continuous sweat and electrolyte monitoring. It offers real-time personalized hydration insights, vibration alerts, and AI-based recommendations to optimize fluid intake before fatigue or injury occurs. By integrating lab-on-skin sensing, cloud-based analytics, and a long-lasting battery system, Connected Hydration improves worker safety, productivity, and endurance in extreme heat environments across global industrial sectors.
In February 2024, Epicore Biosystems Inc. entered into a partnership with the US Anti-Doping Agency (USADA) to advance its microfluidic sweat patch technology for doping detection. This collaboration aims to enable non-invasive sweat biomarker collection for drug testing, improving the efficiency and convenience of anti-doping procedures while providing athletes with real-time health insights. The US Anti-Doping Agency is a US-based nonprofit and non-governmental organization responsible for implementing a comprehensive anti-doping program for ParaPan American sports in the United States.
Major companies operating in the lab-on-skin microfluidic patch market are Epicore Biosystems, Xsensio SA, Persperity Health Inc., Nutromics Pty Ltd., Biolinq Inc., Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc., BioIntelliSense Inc.
North America was the largest region in the lab-on-skin microfluidic patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab-on-skin microfluidic patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lab-on-skin microfluidic patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on microfluidic components and polymer substrates have affected the lab-on-skin microfluidic patch market, increasing costs of wearable diagnostic and therapeutic patches, especially in North America and Europe. However, this drives regional manufacturing initiatives and encourages innovation in alternative, cost-effective materials, supporting localized supply chains and market resilience.
The lab-on-skin microfluidic patch market research report is one of a series of new reports that provides lab-on-skin microfluidic patch market statistics, including lab-on-skin microfluidic patch industry global market size, regional shares, competitors with a lab-on-skin microfluidic patch market share, detailed lab-on-skin microfluidic patch market segments, market trends and opportunities, and any further data you may need to thrive in the lab-on-skin microfluidic patch industry. This lab-on-skin microfluidic patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A lab-on-skin microfluidic patch is a wearable device that combines microfluidic technology with a flexible, skin-adhering surface to continuously collect and analyze biofluids such as sweat, interstitial fluid, or tears. It operates as a compact laboratory on the skin, allowing real-time monitoring of physiological indicators such as electrolytes, glucose, lactate, and hydration levels for applications in health diagnostics, athletic performance, and personalized medicine.
The primary product types of lab-on-skin microfluidic patches include diagnostic patches, therapeutic patches, monitoring patches, and others. Diagnostic patches are skin-worn devices designed to detect and identify biomarkers such as ions, metabolites, or proteins that reflect disease states or physiological conditions. These patches are composed of materials such as polymer-based, paper-based, hybrid, and others. They are used in healthcare monitoring, disease diagnosis, drug delivery, sports and fitness, and other applications, serving end-users such as hospitals and clinics, homecare, research institutes, sports and fitness centers, and others.
The lab-on-skin microfluidic patch market consists of sales of sensors, microfluidic chips, flexible substrates, electrodes, biosensors, hydrogels, and wearable bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lab-on-skin microfluidic patch market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to integration with AI-driven analytics, expansion in personalized medicine, remote patient monitoring growth, adoption in fitness & wellness sectors, technological innovation in patch materials. Major trends in the forecast period include continuous health monitoring, non-invasive diagnostics, personalized medicine devices, sports & fitness analytics, real-time biomarker detection.
The growing focus on personalized medicine is anticipated to drive the expansion of the lab-on-skin microfluidic patch market in the coming years. Personalized medicine is a healthcare approach that tailors medical treatment and preventive strategies to an individual’s genetic, biomarker, and clinical profile to achieve better therapeutic outcomes. The increasing adoption of personalized medicine is supported by advances in genomics and biotechnology, which enable accurate diagnoses and targeted therapies that enhance treatment effectiveness and reduce unnecessary interventions. Lab-on-skin microfluidic patches contribute to this approach by continuously monitoring unique biomarkers, allowing real-time, individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization promoting personalized medicine, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Therefore, the rising emphasis on personalized medicine is propelling the growth of the lab-on-skin microfluidic patch market.
Companies operating in the lab-on-skin microfluidic patch market are increasingly developing advanced microfluidic technologies, such as sweat-sensing patches, to support real-time health monitoring and personalized diagnostics. A sweat-sensing patch is a wearable device that collects and analyzes sweat to track biomarkers, electrolytes, and other physiological indicators continuously. For example, in April 2024, Epicore Biosystems Inc., a US-based digital health company, launched Connected Hydration, a wearable microfluidic patch paired with a mobile application that helps industrial workers prevent dehydration and heat stress through continuous sweat and electrolyte monitoring. It offers real-time personalized hydration insights, vibration alerts, and AI-based recommendations to optimize fluid intake before fatigue or injury occurs. By integrating lab-on-skin sensing, cloud-based analytics, and a long-lasting battery system, Connected Hydration improves worker safety, productivity, and endurance in extreme heat environments across global industrial sectors.
In February 2024, Epicore Biosystems Inc. entered into a partnership with the US Anti-Doping Agency (USADA) to advance its microfluidic sweat patch technology for doping detection. This collaboration aims to enable non-invasive sweat biomarker collection for drug testing, improving the efficiency and convenience of anti-doping procedures while providing athletes with real-time health insights. The US Anti-Doping Agency is a US-based nonprofit and non-governmental organization responsible for implementing a comprehensive anti-doping program for ParaPan American sports in the United States.
Major companies operating in the lab-on-skin microfluidic patch market are Epicore Biosystems, Xsensio SA, Persperity Health Inc., Nutromics Pty Ltd., Biolinq Inc., Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc., BioIntelliSense Inc.
North America was the largest region in the lab-on-skin microfluidic patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab-on-skin microfluidic patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lab-on-skin microfluidic patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on microfluidic components and polymer substrates have affected the lab-on-skin microfluidic patch market, increasing costs of wearable diagnostic and therapeutic patches, especially in North America and Europe. However, this drives regional manufacturing initiatives and encourages innovation in alternative, cost-effective materials, supporting localized supply chains and market resilience.
The lab-on-skin microfluidic patch market research report is one of a series of new reports that provides lab-on-skin microfluidic patch market statistics, including lab-on-skin microfluidic patch industry global market size, regional shares, competitors with a lab-on-skin microfluidic patch market share, detailed lab-on-skin microfluidic patch market segments, market trends and opportunities, and any further data you may need to thrive in the lab-on-skin microfluidic patch industry. This lab-on-skin microfluidic patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A lab-on-skin microfluidic patch is a wearable device that combines microfluidic technology with a flexible, skin-adhering surface to continuously collect and analyze biofluids such as sweat, interstitial fluid, or tears. It operates as a compact laboratory on the skin, allowing real-time monitoring of physiological indicators such as electrolytes, glucose, lactate, and hydration levels for applications in health diagnostics, athletic performance, and personalized medicine.
The primary product types of lab-on-skin microfluidic patches include diagnostic patches, therapeutic patches, monitoring patches, and others. Diagnostic patches are skin-worn devices designed to detect and identify biomarkers such as ions, metabolites, or proteins that reflect disease states or physiological conditions. These patches are composed of materials such as polymer-based, paper-based, hybrid, and others. They are used in healthcare monitoring, disease diagnosis, drug delivery, sports and fitness, and other applications, serving end-users such as hospitals and clinics, homecare, research institutes, sports and fitness centers, and others.
The lab-on-skin microfluidic patch market consists of sales of sensors, microfluidic chips, flexible substrates, electrodes, biosensors, hydrogels, and wearable bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Lab-on-Skin Microfluidic Patch Market Characteristics
3. Lab-on-Skin Microfluidic Patch Market Supply Chain Analysis
4. Global Lab-on-Skin Microfluidic Patch Market Trends and Strategies
5. Lab-on-Skin Microfluidic Patch Market Analysis of End Use Industries
7. Global Lab-on-Skin Microfluidic Patch Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Lab-on-Skin Microfluidic Patch Total Addressable Market (TAM) Analysis for the Market
9. Lab-on-Skin Microfluidic Patch Market Segmentation
10. Lab-on-Skin Microfluidic Patch Market Regional and Country Analysis
11. Asia-Pacific Lab-on-Skin Microfluidic Patch Market
12. China Lab-on-Skin Microfluidic Patch Market
13. India Lab-on-Skin Microfluidic Patch Market
14. Japan Lab-on-Skin Microfluidic Patch Market
15. Australia Lab-on-Skin Microfluidic Patch Market
16. Indonesia Lab-on-Skin Microfluidic Patch Market
17. South Korea Lab-on-Skin Microfluidic Patch Market
18. Taiwan Lab-on-Skin Microfluidic Patch Market
19. South East Asia Lab-on-Skin Microfluidic Patch Market
20. Western Europe Lab-on-Skin Microfluidic Patch Market
21. UK Lab-on-Skin Microfluidic Patch Market
22. Germany Lab-on-Skin Microfluidic Patch Market
23. France Lab-on-Skin Microfluidic Patch Market
24. Italy Lab-on-Skin Microfluidic Patch Market
25. Spain Lab-on-Skin Microfluidic Patch Market
26. Eastern Europe Lab-on-Skin Microfluidic Patch Market
27. Russia Lab-on-Skin Microfluidic Patch Market
28. North America Lab-on-Skin Microfluidic Patch Market
29. USA Lab-on-Skin Microfluidic Patch Market
30. Canada Lab-on-Skin Microfluidic Patch Market
31. South America Lab-on-Skin Microfluidic Patch Market
32. Brazil Lab-on-Skin Microfluidic Patch Market
33. Middle East Lab-on-Skin Microfluidic Patch Market
34. Africa Lab-on-Skin Microfluidic Patch Market
36. Lab-on-Skin Microfluidic Patch Market Competitive Landscape and Company Profiles
37. Lab-on-Skin Microfluidic Patch Market Other Major and Innovative Companies
40. Lab-on-Skin Microfluidic Patch Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Lab-On-Skin Microfluidic Patch Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lab-on-skin microfluidic patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lab-on-skin microfluidic patch? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab-on-skin microfluidic patch market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Diagnostic Patches; Monitoring Patches2) By Material Type: Polymer-Based; Hybrid; Other Material Types
3) By Application: Healthcare Monitoring; Disease Diagnosis; Sports And Fitness; Other Applications
4) By End-User: Hospitals And Clinics; Homecare; Research Institutes; Sports And Fitness Centers; Other End-Users
Subsegments:
1) By Diagnostic Patches: Sweat-Based Microfluidic Diagnostic Patches; Interstitial Fluid Microfluidic Diagnostic Patches; Glucose and Metabolite Detection Microfluidic Patches; Electrolyte and Biomarker Analysis Microfluidic Patches; Multi-Analyte Lab-on-Skin Diagnostic Patches2) By Monitoring Patches: Continuous Hydration Monitoring Microfluidic Patches; Continuous Lactate Monitoring Microfluidic Patches; Electrolyte Balance Monitoring Microfluidic Patches; Stress and Fatigue Monitoring Microfluidic Patches (Biochemical-Based); Personalized Health Monitoring Lab-on-Skin Patches
Companies Mentioned: Epicore Biosystems; Xsensio SA; Persperity Health Inc.; Nutromics Pty Ltd.; Biolinq Inc.; Flow Bio Ltd.; GraphWear Technologies Inc.; GENTAG Inc.; Nemaura Medical Inc.; Kenzen Inc.; Aline Inc.; Eccrine Systems Inc.; Nix Biosensors; Sonera; Zansors LLC; PointFit Technology Co. Ltd.; Bitome Inc.; Arma Biosciences; VivaLNK Inc.; MC10 Inc.; BioIntelliSense Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Lab-on-Skin Microfluidic Patch market report include:- Epicore Biosystems
- Xsensio SA
- Persperity Health Inc.
- Nutromics Pty Ltd.
- Biolinq Inc.
- Flow Bio Ltd.
- GraphWear Technologies Inc.
- GENTAG Inc.
- Nemaura Medical Inc.
- Kenzen Inc.
- Aline Inc.
- Eccrine Systems Inc.
- Nix Biosensors
- Sonera
- Zansors LLC
- PointFit Technology Co. Ltd.
- Bitome Inc.
- Arma Biosciences
- VivaLNK Inc.
- MC10 Inc.
- BioIntelliSense Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.73 Billion |
| Forecasted Market Value ( USD | $ 3.57 Billion |
| Compound Annual Growth Rate | 19.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
